Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-10

FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TROKENDI XR (topiramate) submitted by Supernus Pharmaceuticals, Inc. The approval updates the product under the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROKENDI XR (TOPIRAMATE)

Snippet

SUPPL AP for TROKENDI XR (TOPIRAMATE)